Influenza vaccine recommendations for children and youth for the 2013/2014 season

Area of Science:

• Pediatrics
• Immunology
• Public Health

Background:

• National Advisory Committee on Immunization (NACI) provides annual influenza vaccine recommendations.
• Previous recommendations for pediatric influenza vaccination have been in place since 2012/2013.

Purpose of the Study:

• To update and communicate current recommendations for routine influenza vaccination in children and their close contacts.
• To provide guidance on vaccine type selection based on age and health status.

Main Methods:

• Review of existing evidence and guidelines by the National Advisory Committee on Immunization.
• Consideration of vaccine efficacy, safety, and administration routes.

Main Results:

• Recommendations for routine influenza vaccination in children and close contacts have not changed from the 2012/2013 season.
• Intranasal live attenuated influenza vaccine (LAIV) is the preferred option for healthy children and adolescents.
• For children with chronic health conditions, either LAIV or trivalent inactivated influenza vaccine (TIV) can be used, barring contraindications.
• Trivalent inactivated influenza vaccine (TIV) is suitable for individuals with egg allergies; LAIV is not recommended for this group due to lack of evaluation.

Conclusions:

• Current recommendations emphasize LAIV for healthy children and adolescents.
• Vaccine choice for children with chronic conditions should be individualized.
• TIV is a safe option for those with egg allergies, while LAIV is not yet recommended for this population.